Neogen Chemicals Limited (NSE:NEOGEN)
India · Delayed Price · Currency is INR 2,410.00
-41.60 (-1.70%)
Oct 1, 2026, 3:29 PM IST
Neogen Chemicals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 65,910 | 31,560 | 40,716 | 31,558 | 32,077 | 43,504 | |
Market Cap Growth | 54.77% | -22.49% | 29.02% | -1.62% | -26.27% | 116.59% |
Enterprise Value | 79,812 | 41,358 | 45,762 | 35,928 | 34,451 | 46,175 |
Last Close Price | 2407.10 | 1111.46 | 1541.62 | 1193.60 | 1280.93 | 1734.08 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 179.74 | 109.78 | 116.90 | 88.52 | 64.19 | 97.48 |
Forward PE | 83.75 | 56.48 | 58.52 | 40.91 | 42.03 | 63.74 |
PS Ratio | 7.12 | 3.66 | 5.24 | 4.57 | 4.68 | 8.93 |
PB Ratio | 8.07 | 3.87 | 5.16 | 4.15 | 6.65 | 9.90 |
P/TBV Ratio | 8.08 | 3.87 | 5.16 | 4.16 | 6.67 | 9.91 |
P/OCF Ratio | - | - | 20.78 | - | - | 3085.40 |
PEG Ratio | 1.73 | 1.05 | 1.16 | 1.17 | 1.16 | 1.44 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 8.62 | 4.80 | 5.89 | 5.20 | 5.02 | 9.48 |
EV/EBITDA Ratio | 51.93 | 32.67 | 35.38 | 34.10 | 31.48 | 54.41 |
EV/EBIT Ratio | 64.11 | 37.68 | 42.17 | 41.21 | 36.10 | 61.65 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.71 | 1.71 | 0.76 | 0.54 | 0.77 | 0.52 |
Debt / EBITDA Ratio | 9.10 | 10.18 | 4.39 | 3.73 | 3.32 | 2.64 |
Net Debt / Equity Ratio | 1.70 | 1.70 | 0.75 | 0.52 | 0.56 | 0.26 |
Net Debt / EBITDA Ratio | 9.07 | 10.98 | 4.58 | 3.76 | 2.49 | 1.36 |
Net Debt / FCF Ratio | - | -1.77 | -4.86 | -1.19 | -2.05 | -0.68 |
Asset Turnover | - | 0.37 | 0.49 | 0.55 | 0.74 | 0.76 |
Inventory Turnover | - | 1.09 | 1.24 | 1.15 | 1.62 | 1.78 |
Quick Ratio | - | 0.55 | 0.84 | 0.70 | 0.75 | 1.19 |
Current Ratio | - | 1.17 | 1.36 | 1.49 | 1.60 | 2.26 |
Return on Equity (ROE) | - | 3.58% | 4.50% | 5.74% | 10.84% | 14.34% |
Return on Assets (ROA) | - | 2.95% | 4.23% | 4.33% | 6.44% | 7.25% |
Return on Invested Capital (ROIC) | 4.00% | 4.28% | 5.94% | 6.16% | 10.25% | 12.22% |
Return on Capital Employed (ROCE) | - | 6.40% | 10.70% | 9.30% | 14.80% | 12.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.54% | 0.91% | 0.85% | 1.13% | 1.56% | 1.03% |
FCF Yield | -11.94% | -24.94% | -2.99% | -10.52% | -4.14% | -3.88% |
Dividend Yield | 0.04% | 0.09% | 0.07% | 0.17% | 0.23% | 0.16% |
Payout Ratio | - | 9.18% | 15.16% | 20.98% | 13.73% | 11.76% |
Buyback Yield / Dilution | -0.74% | - | -3.29% | -2.41% | - | -6.88% |
Total Shareholder Return | -0.70% | 0.09% | -3.23% | -2.24% | 0.23% | -6.72% |